Iowa

Five-Year Summary: July 2014 to June 2019

Tables and graphs report on cancer screening and diagnostic services provided through the program in a recent 5-year period. The data represent clinical services funded directly through the NBCCEDP as reported in the April 2020 submission of the NBCCEDP Minimum Data Elements (MDE).

National aggregate data are typically used to report results from the program and as a standard to compare results of grantee programs. Comparing data across grantee programs is not advised due to extensive variation across programs. For information on interpreting the data, refer to Screening Program Data. For information on the program, refer to About the Program.

Program Overview

Women Served through the NBCCEDP
Category Number
Women served [1] 7,750
Women receiving cervical cancer screening and diagnostic services 4,218
Women receiving breast cancer screening and diagnostic services 7,672

Each category reports counts of unduplicated women receiving services within the 5-year period. Women may be counted in more than one category.

1: Women served includes women receiving any screening or diagnostic procedure with services funded through the NBCCEDP.

Data source: April 2020 submission of NBCCEDP Minimum Data Elements (MDE) for Iowa.

Cervical Cancer Services

This pie chart illustrates the distribution of 4,218 women receiving NBCCEDP-funded cervical services from July 2014 to June 2019 by race and ethnicity.

*Slices too small to view were combined into the Other Races slice (1.2%) and include: American Indian/Alaska Native (0.1%), Multiracial (0.6%), and Unknown (0.5%).

This pie chart illustrates the distribution of 4,218 women receiving NBCCEDP-funded cervical services from July 2014 to June 2019 by age.

Cervical Results and Outcomes
Category Number
Pap tests provided 4,975
Pap tests with abnormal results [1] 149
Percentage of Pap tests with abnormal results 3.0
Age-adjusted percentage [2] 2.9
Cervical cancers or premalignant cervical lesions [3] 137
CIN1 or LSIL 87
CIN2 or worse [4] 50
Rate of CIN2 or worse detected per 1,000 Pap tests [4] 10.1
Age-adjusted rate per 1,000 Pap tests [2] 10.6

1: Abnormals include Pap test results of: low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), atypical squamous cells of undetermined significance – cannot exclude HSIL (ASC-H), atypical glandular cells (AGC), and squamous cell cancer.

2: Adjusted to the age distribution of NBCCEDP participants having Pap tests performed in calendar year 2000.

3: Includes LSIL, HSIL, cervical intraepithelial neoplasia (CIN)1, CIN2, CIN3, carcinoma in situ (CIS), and invasive cervical cancer.

4: Includes HSIL, CIN2, CIN3, CIS, and invasive cervical cancer.

Table includes Pap tests provided to women with services funded through the NBCCEDP.

Breast Cancer Services

This pie chart illustrates the distribution of 7,672 women receiving NBCCEDP-funded breast services from July 2014 to June 2019 by race and ethnicity.

*Slices too small to view were combined into the Other Races slice (1.4%) and include: American Indian/Alaska Native (0.2%), Multiracial (0.7%), and Unknown (0.5%).

This pie chart illustrates the distribution of 7,672 women receiving NBCCEDP-funded breast services from July 2014 to June 2019 by age.

Breast Results and Outcomes
Category Number
Mammograms provided 10,456
Mammograms with abnormal results [1] 1,639
Percentage of mammograms with abnormal results 15.7
Age-adjusted percentage [2] 14.2
Breast cancers detected [3] 138
Rate of breast cancers detected per 1,000 mammograms 13.2
Age-adjusted rate per 1,000 mammograms [2] 14.0

1: Abnormals include mammogram results of: suspicious abnormality, highly suggestive of malignancy, and assessment incomplete (further imaging studies or film comparisons required).

2: Adjusted to the age distribution of NBCCEDP participants 40 years of age and older having mammograms performed in calendar year 2000.

3: Breast cancers include invasive breast cancer, ductal carcinoma in situ (DCIS), and other in situ excluding lobular carcinoma in situ (LCIS).

Table includes mammograms provided to women age 40 and older with services funded through the NBCCEDP.

Page last reviewed: August 10, 2020